Tejal Somvanshi
A growing number of young adults in the UK are reported to be taking prescription drugs instead of alcohol in social settings, a trend that has divided medical and public health experts over its implications and risks.
The shift toward prescription medication in place of alcohol has been observed particularly among young people, with the practice facilitated through social media networks. A 22-year-old warehouse worker from the north of England, identified in reporting as “Matt,” describes having made this transition two years ago. According to his account, he began taking a medicine typically prescribed to treat epilepsy and nerve pain, combined with a beta blocker ordinarily used to slow an elevated heart rate and reduce the physical manifestations of anxiety. “It gives me the effects of alcohol without the hangover,” Matt stated, adding that the combination leaves him feeling “euphoric” and helps to quiet anxious thoughts. Guidance on beta blockers is published by the NHS.
Experts cited by the BBC have raised significant concerns about the safety of this practice. Taking such prescription drugs without medical supervision, particularly at elevated doses, presents substantial health risks that in some cases may be life-threatening. Long-term use of these medications outside of prescribed medical contexts can lead to dependency, with users becoming reliant on the drugs to manage social situations. Extended unsupervised use has been associated with increased anxiety and insomnia — outcomes that stand in direct contradiction to the perceived benefits driving initial use. Mental health support resources are provided by the NHS.
The trend has prompted division among medical professionals and harm-reduction specialists regarding its broader implications. Some experts have viewed the reduction in alcohol consumption as representing a potential shift toward harm reduction, pointing to the documented dangers of excessive alcohol use among young adults. Others have expressed more cautious positions, emphasising the dangers inherent in unregulated and unsupervised use of prescription medication, particularly among individuals without medical diagnosis or oversight.
The emergence of this pattern has been positioned within a wider context of documented concerns affecting young people in the UK. Youth mental health challenges, including social anxiety and related conditions, remain significant public health concerns. Social media platforms have been identified as vectors through which information about off-label drug use has been normalised and disseminated among younger demographics. Related reporting on mental health systems and youth wellbeing has examined the wider context. Wider health reporting, including on Giganectar, has also examined youth mental health trends.
The practice reflects a broader intersection of mental health pressures, peer influence mechanisms, and the accessibility of information through digital networks. As the trend continues to be documented, public health authorities and medical professionals remain engaged in assessing both the scale of the phenomenon and its potential consequences for young adult health and wellbeing.
